Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$164.91K$164.91Kderived+42.3% vs Q4 2016 Net Income-$1.57M-$1.57MderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,028,308N/M Operating Cash Flowderived-$319,229N/M Margins · derivedOperating margin-623.6%+168.6 pt vs Q4 2016
Net margin-953.3%+508.0 pt vs Q4 2016
ended Dec 31, 2017 · filed Apr 5, 2018 · 95 d after period end